Psylo is a drug development company that focuses on next-generation psychedelics.
Business Model:
Revenue: $0
Employees: 11-50
Address: .
City: Sydney
State: new south wales
Zip: 2000
Country: AU
Psylo is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Seed Round | 5 | $3.2M |
CaraMed Capital Empath Ventures Lionheart Ventures Main Sequence Ventures Negev Capital CaraMed Capital Empath Ventures Lionheart Ventures Main Sequence Ventures Negev Capital |
10/2022 | Seed | $5M |
Main Sequence Ventures Lionheart Ventures Negev Capital Empath Ventures CaraMed Capital |
10/2021 | Venture Round | $1.1M |
Possible Ventures |
10/2021 | Seed Round | 2 | $798.9k |
Daniel Petre Possible Ventures Daniel Petre Possible Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|